LOUISVILLE, Colo., Nov. 8, 2018 /PRNewswire/ — Eximis Surgical, Inc. today announced it has secured $7.5 million in financing led by Questa Capital, with participation from Venture Investors. Eximis Surgical is developing a transformational surgical platform for the removal of large specimens through small laparoscopic incisions. The Eximis... Read More →
The notorious morcellator, a tool for the laparoscopic removal of uterine fibroids and other tissues, has largely gone into disuse since the FDA issued a black box warning about the devices because of their potential for spreading cancerous cells. Eximis Surgical is filling the gap with a laparoscopic device that it says will not only be safe, but will also offer procedural advantages and result in higher quality tissue specimens for analysis.
Audience at the 25th Annual WSGR Medical Device Conference Voted to Choose Winner San Francisco, June 7, 2017 – MedTech Innovator, the medtech industry’s nonprofit global competition and accelerator, congratulates Eximis Surgical for being selected as its Value Award winner at Wilson... Read More →